Form 4: OmniAb CEO Matthew Foehr Exercises Stock Options, Increases Holdings
SEC Form 4 Filing
OmniAb's CEO, Matthew Foehr, exercised stock options, acquiring a total of 99,434 shares of common stock at prices of $3.68 and $3.75 per share.
Summary
- Matthew Foehr, the President and CEO of OmniAb, Inc., executed stock option exercises on November 25, 2024.
- He acquired 31,074 shares of common stock at a price of $3.68 per share.
- Additionally, he acquired 68,360 shares of common stock at a price of $3.75 per share.
- Following these transactions, Mr. Foehr's direct holdings increased to 3,698,600 shares of common stock.
- The stock options exercised are part of grants that vest over time, with an initial 12.5% vesting after 6 months and the remainder vesting monthly over 42 months.
Sentiment
Score: 7
Explanation: The document reflects a positive action by the CEO, indicating confidence in the company. However, it is a routine filing and not a major event.
Positives
- The CEO's exercise of stock options demonstrates confidence in the company's future prospects.
- The increase in direct holdings aligns the CEO's interests with those of shareholders.
Industry Context
This is a routine filing related to executive compensation and is common for publicly traded companies. It reflects the CEO's participation in the company's equity incentive plans.
Comparison to Industry Standards
- Stock option exercises are a standard form of executive compensation in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
- The vesting schedule of 12.5% after 6 months and the remainder over 42 months is a common practice to incentivize long-term performance and retention.
- Similar filings are regularly made by executives at companies like Regeneron, Amgen, and Biogen, reflecting similar compensation structures.
Stakeholder Impact
- The increase in the CEO's share ownership may be viewed positively by shareholders, aligning management's interests with theirs.
Key Dates
| Date | Description |
|---|---|
| 11/25/2024 | Date of stock option exercises by Matthew Foehr. |
| 11/26/2024 | Date of filing of the SEC Form 4. |
| 12/07/2032 | Expiration date of one of the stock option grants. |
| 04/07/2033 | Expiration date of the other stock option grant. |
Keywords
OmniAb, stock options, Matthew Foehr, insider trading, executive compensation, share ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.